Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Soy isoflavones sensitize cancer cells to radiotherapy.

Hillman GG, Singh-Gupta V.

Free Radic Biol Med. 2011 Jul 15;51(2):289-98. doi: 10.1016/j.freeradbiomed.2011.04.039. Epub 2011 May 4. Review.

PMID:
21605661
2.

Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.

Singh-Gupta V, Joiner MC, Runyan L, Yunker CK, Sarkar FH, Miller S, Gadgeel SM, Konski AA, Hillman GG.

J Thorac Oncol. 2011 Apr;6(4):688-98. doi: 10.1097/JTO.0b013e31821034ae.

3.

Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O.

Nutr Cancer. 2010;62(7):996-1000. doi: 10.1080/01635581.2010.509839.

4.

Genistein can mitigate the effect of radiation on rat lung tissue.

Calveley VL, Jelveh S, Langan A, Mahmood J, Yeung IW, Van Dyk J, Hill RP.

Radiat Res. 2010 May;173(5):602-11. doi: 10.1667/RR1896.1.

5.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP.

J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. Review.

PMID:
20351327
6.

Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.

Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, Sarkar FH, Hillman GG.

Pharm Res. 2010 Jun;27(6):1115-27. doi: 10.1007/s11095-010-0107-9. Epub 2010 Mar 23.

PMID:
20309614
7.

Hypoxia inducible factor 1alpha signaling in fractionated radiation-induced lung injury: role of oxidative stress and tissue hypoxia.

Rabbani ZN, Mi J, Zhang Y, Delong M, Jackson IL, Fleckenstein K, Salahuddin FK, Zhang X, Clary B, Anscher MS, Vujaskovic Z.

Radiat Res. 2010 Feb;173(2):165-74. doi: 10.1667/RR1816.1.

8.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

9.

Effects of genistein following fractionated lung irradiation in mice.

Para AE, Bezjak A, Yeung IW, Van Dyk J, Hill RP.

Radiother Oncol. 2009 Sep;92(3):500-10. doi: 10.1016/j.radonc.2009.04.005. Epub 2009 May 9.

PMID:
19433340
10.

Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.

Singh-Gupta V, Zhang H, Banerjee S, Kong D, Raffoul JJ, Sarkar FH, Hillman GG.

Int J Cancer. 2009 Apr 1;124(7):1675-84. doi: 10.1002/ijc.24015.

11.

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z.

Radiother Oncol. 2009 Jun;91(3):427-32. doi: 10.1016/j.radonc.2008.09.009. Epub 2008 Oct 18.

PMID:
18937989
12.

Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG.

Cancer Res. 2007 Mar 1;67(5):2141-9.

13.

Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.

Raffoul JJ, Banerjee S, Che M, Knoll ZE, Doerge DR, Abrams J, Kucuk O, Sarkar FH, Hillman GG.

Int J Cancer. 2007 Jun 1;120(11):2491-8.

14.

Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.

Hillman GG, Wang Y, Che M, Raffoul JJ, Yudelev M, Kucuk O, Sarkar FH.

BMC Cancer. 2007 Jan 9;7:4.

15.
16.

Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.

Wang Y, Raffoul JJ, Che M, Doerge DR, Joiner MC, Kucuk O, Sarkar FH, Hillman GG.

Radiat Res. 2006 Jul;166(1 Pt 1):73-80.

PMID:
16808622
17.

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass B, Eisbruch A, Lawrence TS, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. Epub 2006 May 2.

PMID:
16647222
18.
19.

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, Yudelev M, Joiner MC, Marples B, Forman JD, Sarkar FH.

Mol Cancer Ther. 2004 Oct;3(10):1271-9.

20.

The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.

Dezso B, Haas GP, Hamzavi F, Kim S, Montecillo EJ, Benson PD, Pontes JE, Maughan RL, Hillman GG.

Clin Cancer Res. 1996 Sep;2(9):1543-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk